Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

6,666 Procter & Gamble Company (The) $PG Shares Sold by Evergreen Capital Management LLC

Procter & Gamble logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Evergreen Capital Management reduced its Procter & Gamble stake by 16.8% in the third quarter, selling 6,666 shares and retaining 32,919 shares valued at approximately $4.78 million. Institutional investors collectively own 65.77% of PG.
  • Procter & Gamble reported quarterly results above expectations, with EPS of $2.00 versus the $1.89 consensus and revenue of $23.28 billion, up 4% year over year.
  • The company declared a quarterly dividend of $1.0885 per share, equivalent to an annualized $4.35 payout and a 2.7% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $168.90.
  • Want to know the moment analysts change their view on Procter & Gamble? Get MarketBeat All Access for $149 a year and keep that rate for life.

Evergreen Capital Management LLC lessened its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 16.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,919 shares of the company's stock after selling 6,666 shares during the quarter. Evergreen Capital Management LLC's holdings in Procter & Gamble were worth $4,782,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Dudley Capital Management LLC boosted its position in shares of Procter & Gamble by 1.7% during the third quarter. Dudley Capital Management LLC now owns 12,311 shares of the company's stock valued at $1,789,000 after buying an additional 210 shares during the last quarter. Gibbs Wealth Management grew its holdings in Procter & Gamble by 34.4% during the third quarter. Gibbs Wealth Management now owns 8,040 shares of the company's stock worth $1,168,000 after buying an additional 2,060 shares in the last quarter. Garrett Wealth Advisory Group LLC raised its position in Procter & Gamble by 1.1% in the 3rd quarter. Garrett Wealth Advisory Group LLC now owns 7,066 shares of the company's stock valued at $1,026,000 after buying an additional 75 shares during the last quarter. Tectonic Advisors LLC raised its position in Procter & Gamble by 9.3% in the 3rd quarter. Tectonic Advisors LLC now owns 78,030 shares of the company's stock valued at $11,336,000 after buying an additional 6,661 shares during the last quarter. Finally, Winthrop Advisory Group LLC lifted its stake in Procter & Gamble by 2.4% during the 3rd quarter. Winthrop Advisory Group LLC now owns 10,618 shares of the company's stock valued at $1,543,000 after acquiring an additional 250 shares in the last quarter. Institutional investors own 65.77% of the company's stock.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $161.21 on Monday. The business's fifty day simple moving average is $148.41 and its 200 day simple moving average is $147.12. The firm has a market capitalization of $373.64 billion, a P/E ratio of 24.28, a price-to-earnings-growth ratio of 4.00 and a beta of 0.39. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, topping the consensus estimate of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The business had revenue of $23.28 billion for the quarter, compared to analysts' expectations of $22.80 billion. During the same quarter in the previous year, the firm earned $1.99 earnings per share. The business's revenue was up 4.0% on a year-over-year basis. As a group, analysts anticipate that Procter & Gamble Company will post 6.98 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble's dividend payout ratio is currently 65.51%.

Analyst Ratings Changes

A number of equities analysts have issued reports on PG shares. BMO Capital Markets lifted their price objective on shares of Procter & Gamble from $169.00 to $170.00 and gave the stock an "outperform" rating in a report on Monday, June 29th. Wells Fargo & Company raised their price target on shares of Procter & Gamble from $164.00 to $180.00 and gave the company an "overweight" rating in a research report on Friday. Weiss Ratings restated a "hold (c)" rating on shares of Procter & Gamble in a report on Monday, September 21st. Sanford C. Bernstein reaffirmed a "market perform" rating and issued a $149.00 price objective on shares of Procter & Gamble in a research report on Monday, August 24th. Finally, UBS Group set a $166.00 price objective on shares of Procter & Gamble in a research report on Friday. Fifteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $168.90.

Read Our Latest Stock Analysis on Procter & Gamble

Insider Buying and Selling

In other Procter & Gamble news, CEO Paul Gama sold 2,225 shares of the firm's stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $323,381.50. Following the completion of the sale, the chief executive officer directly owned 51,124 shares of the company's stock, valued at $7,430,362.16. This trade represents a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marc S. Pritchard sold 4,030 shares of the firm's stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total value of $579,473.70. Following the completion of the sale, the insider directly owned 187,001 shares of the company's stock, valued at $26,888,873.79. This represents a 2.11% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 15,135 shares of company stock worth $2,189,970 in the last three months. Insiders own 0.23% of the company's stock.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
  • Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
  • Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
  • Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
  • Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook

About Procter & Gamble

(Free Report)

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines